1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered: Ranking by Syndromic Multiplex Diagnostic Revenue 1.4 Market Analysis by Type 1.4.1 Global Syndromic Multiplex Diagnostic Market Size Growth Rate by Type: 2020 VS 2026 1.4.2 Gastrointestinal Syndromic Multiplex Diagnostic 1.4.3 Central Nervous System Syndromic Multiplex Diagnostic 1.4.4 Others 1.5 Market by Application 1.5.1 Global Syndromic Multiplex Diagnostic Market Share by Application: 2020 VS 2026 1.5.2 Hospitals 1.5.3 Diagnostics Laboratories 1.5.4 Research Institutes 1.5.5 Others 1.6 Coronavirus Disease 2019 (Covid-19): Syndromic Multiplex Diagnostic Industry Impact 1.6.1 How the Covid-19 is Affecting the Syndromic Multiplex Diagnostic Industry 1.6.1.1 Syndromic Multiplex Diagnostic Business Impact Assessment - Covid-19 1.6.1.2 Supply Chain Challenges 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products 1.6.2 Market Trends and Syndromic Multiplex Diagnostic Potential Opportunities in the COVID-19 Landscape 1.6.3 Measures / Proposal against Covid-19 1.6.3.1 Government Measures to Combat Covid-19 Impact 1.6.3.2 Proposal for Syndromic Multiplex Diagnostic Players to Combat Covid-19 Impact 1.7 Study Objectives 1.8 Years Considered 2 Global Growth Trends by Regions 2.1 Syndromic Multiplex Diagnostic Market Perspective (2015-2026) 2.2 Syndromic Multiplex Diagnostic Growth Trends by Regions 2.2.1 Syndromic Multiplex Diagnostic Market Size by Regions: 2015 VS 2020 VS 2026 2.2.2 Syndromic Multiplex Diagnostic Historic Market Share by Regions (2015-2020) 2.2.3 Syndromic Multiplex Diagnostic Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Porter’s Five Forces Analysis 2.3.5 Syndromic Multiplex Diagnostic Market Growth Strategy 2.3.6 Primary Interviews with Key Syndromic Multiplex Diagnostic Players (Opinion Leaders) 3 Competition Landscape by Key Players 3.1 Global Top Syndromic Multiplex Diagnostic Players by Market Size 3.1.1 Global Top Syndromic Multiplex Diagnostic Players by Revenue (2015-2020) 3.1.2 Global Syndromic Multiplex Diagnostic Revenue Market Share by Players (2015-2020) 3.1.3 Global Syndromic Multiplex Diagnostic Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.2 Global Syndromic Multiplex Diagnostic Market Concentration Ratio 3.2.1 Global Syndromic Multiplex Diagnostic Market Concentration Ratio (CR5 and HHI) 3.2.2 Global Top 10 and Top 5 Companies by Syndromic Multiplex Diagnostic Revenue in 2019 3.3 Syndromic Multiplex Diagnostic Key Players Head office and Area Served 3.4 Key Players Syndromic Multiplex Diagnostic Product Solution and Service 3.5 Date of Enter into Syndromic Multiplex Diagnostic Market 3.6 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2015-2026) 4.1 Global Syndromic Multiplex Diagnostic Historic Market Size by Type (2015-2020) 4.2 Global Syndromic Multiplex Diagnostic Forecasted Market Size by Type (2021-2026) 5 Syndromic Multiplex Diagnostic Breakdown Data by Application (2015-2026) 5.1 Global Syndromic Multiplex Diagnostic Market Size by Application (2015-2020) 5.2 Global Syndromic Multiplex Diagnostic Forecasted Market Size by Application (2021-2026) 6 North America 6.1 North America Syndromic Multiplex Diagnostic Market Size (2015-2020) 6.2 Syndromic Multiplex Diagnostic Key Players in North America (2019-2020) 6.3 North America Syndromic Multiplex Diagnostic Market Size by Type (2015-2020) 6.4 North America Syndromic Multiplex Diagnostic Market Size by Application (2015-2020) 7 Europe 7.1 Europe Syndromic Multiplex Diagnostic Market Size (2015-2020) 7.2 Syndromic Multiplex Diagnostic Key Players in Europe (2019-2020) 7.3 Europe Syndromic Multiplex Diagnostic Market Size by Type (2015-2020) 7.4 Europe Syndromic Multiplex Diagnostic Market Size by Application (2015-2020) 8 Asia-Pacific 8.1 Asia-Pacific Syndromic Multiplex Diagnostic Market Size (2015-2020) 8.2 Syndromic Multiplex Diagnostic Key Players in Asia-Pacific (2019-2020) 8.3 Asia-Pacific Syndromic Multiplex Diagnostic Market Size by Type (2015-2020) 8.4 Asia-Pacific Syndromic Multiplex Diagnostic Market Size by Application (2015-2020) (2015-2020) (2015-2020) 9 Key Players Profiles 9.1 Abbott 9.1.1 Abbott Company Details 9.1.2 Abbott Business Overview and Its Total Revenue 9.1.3 Abbott Syndromic Multiplex Diagnostic Introduction 9.1.4 Abbott Revenue in Syndromic Multiplex Diagnostic Business (2015-2020)) 9.1.5 Abbott Recent Development 9.2 Hologic 9.2.1 Hologic Company Details 9.2.2 Hologic Business Overview and Its Total Revenue 9.2.3 Hologic Syndromic Multiplex Diagnostic Introduction 9.2.4 Hologic Revenue in Syndromic Multiplex Diagnostic Business (2015-2020) 9.2.5 Hologic Recent Development 9.3 Bosch 9.3.1 Bosch Company Details 9.3.2 Bosch Business Overview and Its Total Revenue 9.3.3 Bosch Syndromic Multiplex Diagnostic Introduction 9.3.4 Bosch Revenue in Syndromic Multiplex Diagnostic Business (2015-2020) 9.3.5 Bosch Recent Development 9.4 Danaher 9.4.1 Danaher Company Details 9.4.2 Danaher Business Overview and Its Total Revenue 9.4.3 Danaher Syndromic Multiplex Diagnostic Introduction 9.4.4 Danaher Revenue in Syndromic Multiplex Diagnostic Business (2015-2020) 9.4.5 Danaher Recent Development 9.5 Johnson & Johnson 9.5.1 Johnson & Johnson Company Details 9.5.2 Johnson & Johnson Business Overview and Its Total Revenue 9.5.3 Johnson & Johnson Syndromic Multiplex Diagnostic Introduction 9.5.4 Johnson & Johnson Revenue in Syndromic Multiplex Diagnostic Business (2015-2020) 9.5.5 Johnson & Johnson Recent Development 9.6 Danaher 9.6.1 Danaher Company Details 9.6.2 Danaher Business Overview and Its Total Revenue 9.6.3 Danaher Syndromic Multiplex Diagnostic Introduction 9.6.4 Danaher Revenue in Syndromic Multiplex Diagnostic Business (2015-2020) 9.6.5 Danaher Recent Development 9.7 Bio-Rad Laboratories 9.7.1 Bio-Rad Laboratories Company Details 9.7.2 Bio-Rad Laboratories Business Overview and Its Total Revenue 9.7.3 Bio-Rad Laboratories Syndromic Multiplex Diagnostic Introduction 9.7.4 Bio-Rad Laboratories Revenue in Syndromic Multiplex Diagnostic Business (2015-2020) 9.7.5 Bio-Rad Laboratories Recent Development 9.8 Luminex 9.8.1 Luminex Company Details 9.8.2 Luminex Business Overview and Its Total Revenue 9.8.3 Luminex Syndromic Multiplex Diagnostic Introduction 9.8.4 Luminex Revenue in Syndromic Multiplex Diagnostic Business (2015-2020) 9.8.5 Luminex Recent Development 9.9 bioMérieux 9.9.1 bioMérieux Company Details 9.9.2 bioMérieux Business Overview and Its Total Revenue 9.9.3 bioMérieux Syndromic Multiplex Diagnostic Introduction 9.9.4 bioMérieux Revenue in Syndromic Multiplex Diagnostic Business (2015-2020) 9.9.5 bioMérieux Recent Development 9.10 Qiagen 9.10.1 Qiagen Company Details 9.10.2 Qiagen Business Overview and Its Total Revenue 9.10.3 Qiagen Syndromic Multiplex Diagnostic Introduction 9.10.4 Qiagen Revenue in Syndromic Multiplex Diagnostic Business (2015-2020) 9.10.5 Qiagen Recent Development 9.11 Alveo Technologies 10.11.1 Alveo Technologies Company Details 10.11.2 Alveo Technologies Business Overview and Its Total Revenue 10.11.3 Alveo Technologies Syndromic Multiplex Diagnostic Introduction 10.11.4 Alveo Technologies Revenue in Syndromic Multiplex Diagnostic Business (2015-2020) 10.11.5 Alveo Technologies Recent Development 9.12 Mesa Biotech 10.12.1 Mesa Biotech Company Details 10.12.2 Mesa Biotech Business Overview and Its Total Revenue 10.12.3 Mesa Biotech Syndromic Multiplex Diagnostic Introduction 10.12.4 Mesa Biotech Revenue in Syndromic Multiplex Diagnostic Business (2015-2020) 10.12.5 Mesa Biotech Recent Development 9.13 Applied BioCode 10.13.1 Applied BioCode Company Details 10.13.2 Applied BioCode Business Overview and Its Total Revenue 10.13.3 Applied BioCode Syndromic Multiplex Diagnostic Introduction 10.13.4 Applied BioCode Revenue in Syndromic Multiplex Diagnostic Business (2015-2020) 10.13.5 Applied BioCode Recent Development 9.14 Akonni Biosystems 10.14.1 Akonni Biosystems Company Details 10.14.2 Akonni Biosystems Business Overview and Its Total Revenue 10.14.3 Akonni Biosystems Syndromic Multiplex Diagnostic Introduction 10.14.4 Akonni Biosystems Revenue in Syndromic Multiplex Diagnostic Business (2015-2020) 10.14.5 Akonni Biosystems Recent Development 9.15 Diagenode Diagnostics 10.15.1 Diagenode Diagnostics Company Details 10.15.2 Diagenode Diagnostics Business Overview and Its Total Revenue 10.15.3 Diagenode Diagnostics Syndromic Multiplex Diagnostic Introduction 10.15.4 Diagenode Diagnostics Revenue in Syndromic Multiplex Diagnostic Business (2015-2020) 10.15.5 Diagenode Diagnostics Recent Development 10 Analyst's Viewpoints/Conclusions 11 Appendix 11.1 Research Methodology 11.1.1 Methodology/Research Approach 11.1.2 Data Source 11.2 Disclaimer 11.3 Author Details

List of Tables Table 1. Syndromic Multiplex Diagnostic Key Market Segments Table 2. Key Players Covered: Ranking by Syndromic Multiplex Diagnostic Revenue Table 3. Ranking of Global Top Syndromic Multiplex Diagnostic Manufacturers by Revenue (US$ Million) in 2019 Table 4. Global Syndromic Multiplex Diagnostic Market Size Growth Rate by Type (US$ Million): 2020 VS 2026 Table 5. Key Players of Gastrointestinal Syndromic Multiplex Diagnostic Table 6. Key Players of Central Nervous System Syndromic Multiplex Diagnostic Table 7. Key Players of Others Table 8. COVID-19 Impact Global Market: (Four Syndromic Multiplex Diagnostic Market Size Forecast Scenarios) Table 9. Opportunities and Trends for Syndromic Multiplex Diagnostic Players in the COVID-19 Landscape Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis Table 11. Key Regions/Countries Measures against Covid-19 Impact Table 12. Proposal for Syndromic Multiplex Diagnostic Players to Combat Covid-19 Impact Table 13. Global Syndromic Multiplex Diagnostic Market Size Growth by Application (US$ Million): 2020 VS 2026 Table 14. Global Syndromic Multiplex Diagnostic Market Size by Regions (US$ Million): 2020 VS 2026 Table 15. Global Syndromic Multiplex Diagnostic Market Size by Regions (2015-2020) (US$ Million) Table 16. Global Syndromic Multiplex Diagnostic Market Share by Regions (2015-2020) Table 17. Global Syndromic Multiplex Diagnostic Forecasted Market Size by Regions (2021-2026) (US$ Million) Table 18. Global Syndromic Multiplex Diagnostic Market Share by Regions (2021-2026) Table 19. Market Top Trends Table 20. Key Drivers: Impact Analysis Table 21. Key Challenges Table 22. Syndromic Multiplex Diagnostic Market Growth Strategy Table 23. Main Points Interviewed from Key Syndromic Multiplex Diagnostic Players Table 24. Global Syndromic Multiplex Diagnostic Revenue by Players (2015-2020) (Million US$) Table 25. Global Syndromic Multiplex Diagnostic Market Share by Players (2015-2020) Table 26. Global Top Syndromic Multiplex Diagnostic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Syndromic Multiplex Diagnostic as of 2019) Table 27. Global Syndromic Multiplex Diagnostic by Players Market Concentration Ratio (CR5 and HHI) Table 28. Key Players Headquarters and Area Served Table 29. Key Players Syndromic Multiplex Diagnostic Product Solution and Service Table 30. Date of Enter into Syndromic Multiplex Diagnostic Market Table 31. Mergers & Acquisitions, Expansion Plans Table 32. Global Syndromic Multiplex Diagnostic Market Size by Type (2015-2020) (Million US$) Table 33. Global Syndromic Multiplex Diagnostic Market Size Share by Type (2015-2020) Table 34. Global Syndromic Multiplex Diagnostic Revenue Market Share by Type (2021-2026) Table 35. Global Syndromic Multiplex Diagnostic Market Size Share by Application (2015-2020) Table 36. Global Syndromic Multiplex Diagnostic Market Size by Application (2015-2020) (Million US$) Table 37. Global Syndromic Multiplex Diagnostic Market Size Share by Application (2021-2026) Table 38. North America Key Players Syndromic Multiplex Diagnostic Revenue (2019-2020) (Million US$) Table 39. North America Key Players Syndromic Multiplex Diagnostic Market Share (2019-2020) Table 40. North America Syndromic Multiplex Diagnostic Market Size by Type (2015-2020) (Million US$) Table 41. North America Syndromic Multiplex Diagnostic Market Share by Type (2015-2020) Table 42. North America Syndromic Multiplex Diagnostic Market Size by Application (2015-2020) (Million US$) Table 43. North America Syndromic Multiplex Diagnostic Market Share by Application (2015-2020) Table 44. Europe Key Players Syndromic Multiplex Diagnostic Revenue (2019-2020) (Million US$) Table 45. Europe Key Players Syndromic Multiplex Diagnostic Market Share (2019-2020) Table 46. Europe Syndromic Multiplex Diagnostic Market Size by Type (2015-2020) (Million US$) Table 47. Europe Syndromic Multiplex Diagnostic Market Share by Type (2015-2020) Table 48. Europe Syndromic Multiplex Diagnostic Market Size by Application (2015-2020) (Million US$) Table 49. Europe Syndromic Multiplex Diagnostic Market Share by Application (2015-2020) Table 50. Asia-Pacific Key Players Syndromic Multiplex Diagnostic Revenue (2019-2020) (Million US$) Table 51. Asia-Pacific Key Players Syndromic Multiplex Diagnostic Market Share (2019-2020) Table 52. Asia-Pacific Syndromic Multiplex Diagnostic Market Size by Type (2015-2020) (Million US$) Table 53. Asia-Pacific Syndromic Multiplex Diagnostic Market Share by Type (2015-2020) Table 54. Asia-Pacific Syndromic Multiplex Diagnostic Market Size by Application (2015-2020) (Million US$) Table 55. Asia-Pacific Syndromic Multiplex Diagnostic Market Share by Application (2015-2020) Table 56. Abbott Company Details Table 57. Abbott Business Overview Table 58. Abbott Product Table 59. Abbott Revenue in Syndromic Multiplex Diagnostic Business (2015-2020) (Million US$) Table 60. Abbott Recent Development Table 61. Hologic Company Details Table 62. Hologic Business Overview Table 63. Hologic Product Table 64. Hologic Revenue in Syndromic Multiplex Diagnostic Business (2015-2020) (Million US$) Table 65. Hologic Recent Development Table 66. Bosch Company Details Table 67. Bosch Business Overview Table 68. Bosch Product Table 69. Bosch Revenue in Syndromic Multiplex Diagnostic Business (2015-2020) (Million US$) Table 70. Bosch Recent Development Table 71. Danaher Company Details Table 72. Danaher Business Overview Table 73. Danaher Product Table 74. Danaher Revenue in Syndromic Multiplex Diagnostic Business (2015-2020) (Million US$) Table 75. Danaher Recent Development Table 76. Johnson & Johnson Company Details Table 77. Johnson & Johnson Business Overview Table 78. Johnson & Johnson Product Table 79. Johnson & Johnson Revenue in Syndromic Multiplex Diagnostic Business (2015-2020) (Million US$) Table 80. Johnson & Johnson Recent Development Table 81. Danaher Company Details Table 82. Danaher Business Overview Table 83. Danaher Product Table 84. Danaher Revenue in Syndromic Multiplex Diagnostic Business (2015-2020) (Million US$) Table 85. Danaher Recent Development Table 86. Bio-Rad Laboratories Company Details Table 87. Bio-Rad Laboratories Business Overview Table 88. Bio-Rad Laboratories Product Table 89. Bio-Rad Laboratories Revenue in Syndromic Multiplex Diagnostic Business (2015-2020) (Million US$) Table 90. Bio-Rad Laboratories Recent Development Table 91. Luminex Business Overview Table 92. Luminex Product Table 93. Luminex Company Details Table 94. Luminex Revenue in Syndromic Multiplex Diagnostic Business (2015-2020) (Million US$) Table 95. Luminex Recent Development Table 96. bioMérieux Company Details Table 97. bioMérieux Business Overview Table 98. bioMérieux Product Table 99. bioMérieux Revenue in Syndromic Multiplex Diagnostic Business (2015-2020) (Million US$) Table 100. bioMérieux Recent Development Table 101. Qiagen Company Details Table 102. Qiagen Business Overview Table 103. Qiagen Product Table 104. Qiagen Revenue in Syndromic Multiplex Diagnostic Business (2015-2020) (Million US$) Table 105. Qiagen Recent Development Table 106. Alveo Technologies Company Details Table 107. Alveo Technologies Business Overview Table 108. Alveo Technologies Product Table 109. Alveo Technologies Revenue in Syndromic Multiplex Diagnostic Business (2015-2020) (Million US$) Table 110. Alveo Technologies Recent Development Table 111. Mesa Biotech Company Details Table 112. Mesa Biotech Business Overview Table 113. Mesa Biotech Product Table 114. Mesa Biotech Revenue in Syndromic Multiplex Diagnostic Business (2015-2020) (Million US$) Table 115. Mesa Biotech Recent Development Table 116. Applied BioCode Company Details Table 117. Applied BioCode Business Overview Table 118. Applied BioCode Product Table 119. Applied BioCode Revenue in Syndromic Multiplex Diagnostic Business (2015-2020) (Million US$) Table 120. Applied BioCode Recent Development Table 121. Akonni Biosystems Company Details Table 122. Akonni Biosystems Business Overview Table 123. Akonni Biosystems Product Table 124. Akonni Biosystems Revenue in Syndromic Multiplex Diagnostic Business (2015-2020) (Million US$) Table 125. Akonni Biosystems Recent Development Table 126. Diagenode Diagnostics Company Details Table 127. Diagenode Diagnostics Business Overview Table 128. Diagenode Diagnostics Product Table 129. Diagenode Diagnostics Revenue in Syndromic Multiplex Diagnostic Business (2015-2020) (Million US$) Table 130. Diagenode Diagnostics Recent Development Table 131. Research Programs/Design for This Report Table 132. Key Data Information from Secondary Sources Table 133. Key Data Information from Primary Sources List of Figures Figure 1. Global Syndromic Multiplex Diagnostic Market Share by Type: 2020 VS 2026 Figure 2. Gastrointestinal Syndromic Multiplex Diagnostic Features Figure 3. Central Nervous System Syndromic Multiplex Diagnostic Features Figure 4. Others Features Figure 5. Global Syndromic Multiplex Diagnostic Market Share by Application: 2020 VS 2026 Figure 6. Hospitals Case Studies Figure 7. Diagnostics Laboratories Case Studies Figure 8. Research Institutes Case Studies Figure 9. Others Case Studies Figure 10. Syndromic Multiplex Diagnostic Report Years Considered Figure 11. Global Syndromic Multiplex Diagnostic Market Size YoY Growth 2015-2026 (US$ Million) Figure 12. Global Syndromic Multiplex Diagnostic Market Share by Regions: 2020 VS 2026 Figure 13. Global Syndromic Multiplex Diagnostic Market Share by Regions (2021-2026) Figure 14. Porter's Five Forces Analysis Figure 15. Global Syndromic Multiplex Diagnostic Market Share by Players in 2019 Figure 16. Global Top Syndromic Multiplex Diagnostic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Syndromic Multiplex Diagnostic as of 2019 Figure 17. The Top 10 and 5 Players Market Share by Syndromic Multiplex Diagnostic Revenue in 2019 Figure 18. North America Syndromic Multiplex Diagnostic Market Size YoY Growth (2015-2020) (Million US$) Figure 19. Europe Syndromic Multiplex Diagnostic Market Size YoY Growth (2015-2020) (Million US$) Figure 20. Asia-Pacific Syndromic Multiplex Diagnostic Market Size YoY Growth (2015-2020) (Million US$) Figure 21. Abbott Total Revenue (US$ Million): 2019 Compared with 2018 Figure 22. Abbott Revenue Growth Rate in Syndromic Multiplex Diagnostic Business (2015-2020) Figure 23. Hologic Total Revenue (US$ Million): 2019 Compared with 2018 Figure 24. Hologic Revenue Growth Rate in Syndromic Multiplex Diagnostic Business (2015-2020) Figure 25. Bosch Total Revenue (US$ Million): 2019 Compared with 2018 Figure 26. Bosch Revenue Growth Rate in Syndromic Multiplex Diagnostic Business (2015-2020) Figure 27. Danaher Total Revenue (US$ Million): 2019 Compared with 2018 Figure 28. Danaher Revenue Growth Rate in Syndromic Multiplex Diagnostic Business (2015-2020) Figure 29. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018 Figure 30. Johnson & Johnson Revenue Growth Rate in Syndromic Multiplex Diagnostic Business (2015-2020) Figure 31. Danaher Total Revenue (US$ Million): 2019 Compared with 2018 Figure 32. Danaher Revenue Growth Rate in Syndromic Multiplex Diagnostic Business (2015-2020) Figure 33. Bio-Rad Laboratories Total Revenue (US$ Million): 2019 Compared with 2018 Figure 34. Bio-Rad Laboratories Revenue Growth Rate in Syndromic Multiplex Diagnostic Business (2015-2020) Figure 35. Luminex Total Revenue (US$ Million): 2019 Compared with 2018 Figure 36. Luminex Revenue Growth Rate in Syndromic Multiplex Diagnostic Business (2015-2020) Figure 37. bioMérieux Total Revenue (US$ Million): 2019 Compared with 2018 Figure 38. bioMérieux Revenue Growth Rate in Syndromic Multiplex Diagnostic Business (2015-2020) Figure 39. Qiagen Total Revenue (US$ Million): 2019 Compared with 2018 Figure 40. Qiagen Revenue Growth Rate in Syndromic Multiplex Diagnostic Business (2015-2020) Figure 41. Alveo Technologies Total Revenue (US$ Million): 2019 Compared with 2018 Figure 42. Alveo Technologies Revenue Growth Rate in Syndromic Multiplex Diagnostic Business (2015-2020) Figure 43. Mesa Biotech Total Revenue (US$ Million): 2019 Compared with 2018 Figure 44. Mesa Biotech Revenue Growth Rate in Syndromic Multiplex Diagnostic Business (2015-2020) Figure 45. Applied BioCode Total Revenue (US$ Million): 2019 Compared with 2018 Figure 46. Applied BioCode Revenue Growth Rate in Syndromic Multiplex Diagnostic Business (2015-2020) Figure 47. Akonni Biosystems Total Revenue (US$ Million): 2019 Compared with 2018 Figure 48. Akonni Biosystems Revenue Growth Rate in Syndromic Multiplex Diagnostic Business (2015-2020) Figure 49. Diagenode Diagnostics Total Revenue (US$ Million): 2019 Compared with 2018 Figure 50. Diagenode Diagnostics Revenue Growth Rate in Syndromic Multiplex Diagnostic Business (2015-2020) Figure 51. Bottom-up and Top-down Approaches for This Report Figure 52. Data Triangulation Figure 53. Key Executives Interviewed

Abbott Hologic Bosch Danaher Johnson & Johnson Danaher Bio-Rad Laboratories Luminex bioMérieux Qiagen Alveo Technologies Mesa Biotech Applied BioCode Akonni Biosystems Diagenode Diagnostics